Alnylam Pharmaceuticals – New Office
Alnylam CEO on what is next for heart disease drug
RNAi Therapeutics - How this New Class of Medicines Works
Get to Know Alnylam - The Leader in RNAi Therapeutics
Lernen Sie Alnylam kennen - ein führendes Unternehmen in RNAi-Therapeutika
Founder Stories: John Maraganore, CEO of Alnylam pioneering RNAi therapeutics
RNAi, vielversprechendes Potenzial für eine neue Klasse von Medikamenten
How do RNAi Therapeutics Treat Disease?
Cramer’s Stop Trading: Alnylam Pharma
How Can Unwanted Proteins Cause or Contribute to Disease?
Alnylam Pharmaceuticals ALNY Q1 2024 Earnings Presentation
Alnylam Pharmaceuticals ALNY Q4 2023 Earnings Presentation
A Conversation with One of Our Clients: Alnylam Pharmaceuticals
First Approved Treatment using RNAi – Alnylam Pharmaceuticals’ and BIO Chair John Maraganore
Alnylam(アルナイラム)企業紹介 - RNAi治療のリーディングカンパニー
Founder Stories: John Maraganore, CEO of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals CMO, Dr. Akshay Vaishnaw, Explains RNAi
What is RNAi and How Do RNAi-based Medicines Work?
ALNYLAM unveil UK headquarters | Maidenhead, England